Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Imfinzi granted FDA Priority Review for the treatment of patients with extensive-stage small cell lung cancer
-
Calquence approved in the US for adult patients with chronic lymphocytic leukaemia
-
Harvard Business Review names Pascal Soriot among ‘Best Performing Top 100 CEOs in the World’ 2019
-
Qtrilmet approved in the EU for the treatment of type-2 diabetes
-
US FDA accepts regulatory submission for selumetinib in neurofibromatosis type 1 and grants Priority Review
-
Anifrolumab demonstrated superiority across multiple efficacy endpoints in patients with systemic lupus erythematosus in Phase III TULIP 2 trial
-
Roxadustat Phase III programme pooled analyses showed positive efficacy and no increased cardiovascular risk in patients with anaemia from chronic kidney disease
-
Roxadustat significantly increased haemoglobin levels for chronic kidney disease patients with anaemia in Phase III OLYMPUS and ROCKIES trials
-
Calquence data to show improved progression-free survival in Phase III front-line chronic lymphocytic leukaemia trial at ASH 2019 Annual Meeting
-
AstraZeneca announces three large-scale initiatives in China to advance global medicine research and development
Latest articles and press releases
All of our latest press releases and articles are available to explore
